January 13, 2022
Article
Shortages of health care workers and an increase in COVID-19 cases has put a severe strain on the health care system. Thus, the opportunity to reduce the hospitalizations for other conditions and expand outpatient treatment opportunities should be welcomed.
December 08, 2021
A case series observation study found a slightly higher risk of Guillain-Barre syndrome among Medicare beneficiaries within 42 days after receiving the recombinant zoster vaccine Shingrix, but no changes are needed to guidance recommending the vaccine, investigators said.
July 26, 2021
This approval of the non-live, recombinant sub-unit adjuvanted vaccine, Shingrix, is for the prevention of shingles in adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression.
This therapy becomes the first single-dose infusion to treat acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth.
November 12, 2020
CDC and WHO Data shows a 50% increase worldwide from 3 years ago.
October 23, 2020
“The compound appears to be safe and well-tolerated, [and we observed] excellent efficacy based on a very small sample size,” Peter G. Pappas, MD, said.
January 10, 2020
A closer look at the 2018 enterovirus A71 outbreak in Colorado highlights the need for non-sterile site testing to detect infections.
January 03, 2020
Treating parents colonized with S aureus reduced neonatal colonization with concordant S aureus strains when compared to placebo.
December 20, 2019
How many nursing homes have these microbes?
December 19, 2019
Global efforts to eliminate measles took a step backward, with the number of cases rising to 353,236 in 2018, up 167% from 132,413 cases in 2016.
